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Background: Gambling disorder, recognized by the DSM-5 as a behavioral addiction, affects 0.4 
to 1.6% of adults worldwide, and is highly comorbid with other mental health disorders, 
particularly substance use disorders (SUDs). Objectives: to provide a concise primer on the 
relationship between gambling disorder and SUDs, focusing on phenomenology/clinical 
presentation, co-morbidity, familiality, cognition, neuroanatomy/neurochemistry, and  treatment. 
Methods: Selective review of the literature. Results: Scientific evidence shows that gambling and 
SUDs have consistently high rates of comorbidity, similar clinical presentations, and some 
genetic and physiological overlap.  Several treatment approaches show promise for gambling 
disorder, some of which have previously been effective for SUDs. Scientific Significance: It is 
hoped that recognition of overlap between gambling disorder and SUDs in terms of 
phenomenology and neurobiology will signal novel treatment approaches and raise the profile of 
this neglected condition.  
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Introduction 
Gambling disorder (otherwise known as pathological gambling) is a psychiatric condition 
characterized by persistent and recurrent maladaptive patterns of gambling behavior, leading to 
impaired functioning. It is associated with reduced quality of life, and high rates of bankruptcy, 
divorce, and incarceration.1 Although most people who engage in one or more forms of gambling 
do so responsibly and without undue negative impact on life, some individuals find that they 
become preoccupied with gambling and it has multiple negative consequences. For these people, 
their gambling behavior has devastating consequences that impact the individual, his or her 
family, and society.2 National studies and one meta-analysis of state and regional surveys suggest 
that the prevalence of gambling disorder in the general United States population ranges from 
0.42% to 1.9%.3,4 Similar rates of gambling disorder have been reported in other countries.2 Data 
also suggest that money spent on gambling around the world, both online and in gambling 
establishments, has grown steadily over the last twenty years.5 With the growth of gambling 
opportunities may come increased problematic gambling behavior. Individuals seeking treatment 
for substance use disorders (SUDs) may be particularly vulnerable to developing a gambling 
disorder.6 As such, recognition of gambling disorder, its relationship to SUDs, and its treatment 
appear worth of attention from a global public health perspective.  
Far from being an exclusively modern formulation, excessive gambling behaviors have 
been reported for millennia across cultures and have been discussed in the medical literature 
since the early 1800s.2 However, pathological forms of gambling have only been recognized 
fairly recently by psychiatric nosological classification systems. Though recognized by both 
Kraepelin and Bleuler, disordered gambling behavior was first formally recognized with the 
inclusion of pathological gambling as a ‘Disorder of Impulse Control’ in the Diagnostic and 
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Statistical Manual Version III (DSM-III).7 Subsequent revisions of DSM modeled the diagnostic 
criteria on those of substance dependence, recognizing the phenomenological parallels between 
these two types of disorder. The disorder was categorized as an “Impulse-Control Disorders Not 
Elsewhere Classified,” along with other disorders such as kleptomania, pyromania, and 
trichotillomania. The Diagnostic and Statistical Manual version 5 (DSM-5)8 reflects an important 
departure from DSM-IV-TR9 as the current chapter “Substance-Related and Addictive 
Disorders” now includes Gambling Disorder, formerly listed with the “Impulse Control 
Disorders Not Elsewhere Classified.”8  
The placement of gambling disorder in the most recent nosological revision is likely to 
improve recognition of the disorder, especially among substance abusers who are at high risk for 
gambling problems.6 The name has been changed from pathological gambling to “gambling 
disorder,” mainly to reduce stigma attached to the word “pathological.”  The DSM-5 diagnosis 
requires that 4 of 9 symptoms be endorsed to qualify for the diagnosis of gambling disorder. This 
is a change from DSM-IV-TR wherein 5 of 10 symptoms were required. DSM-5 eliminated the 
symptoms that the gambling resulted in illegal acts as it has been shown to have a low 
prevalence with its elimination having little or no effect on the information associated with the 
diagnosis. As with the DSM-IV, the criteria for gambling disorder mirror those used for the 
SUDs: tolerance (needing to gamble with increasing amount of money), withdrawal (restless or 
irritable when cutting back), and compulsive use (preoccupied with gambling, chasing losses, 
repeated unsuccessful attempts to cut control gambling, and gambling as a way of escaping from 
problems) are the cardinal features. The adverse consequences of addiction are also reflected in 
the remaining symptoms (lying to others, jeopardizing important relationships, and relying on 
others financially). Unlike the DSM-5 substance use disorders which have been modified to 
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include craving or urge as a possible diagnostic criterion, no such addition was made for 
gambling disorder. 
 There exist several comprehensive reviews of specific aspects of gambling disorder10-15 
In view of recent proposed reclassification of pathological forms of gambling alongside SUDs, 
the aim of this paper is to provide a concise primer examining overlap between gambling 
disorder and the SUDs, incorporating very recent evidence derived from the neurosciences. We 
highlight implications for neurobiological models and new treatment directions, along with 
limitations of this approach and areas in which research is lacking.  
 
Phenomenology and clinical features 
Diagnostic criteria for DSM-5 gambling disorder show substantive parallels with those 
for SUDs, reflecting the derivation of former criteria from those for the latter. Both sets of 
criteria include inter alia preoccupation, tolerance, repeated unsuccessful attempts to stop the 
pathological behavior, restlessness/irritability when attempting to resist the pathological behavior, 
and escalation (e.g. in frequency or ‘amount’) over time. Only a small proportion of the individuals 
who are suffering from gambling disorder seek formal treatment.16 Approximately one-third of 
individuals with gambling disorder recover from their illness episode without accessing formal 
treatment services17 (similar to the rates seen in other addictive disorders, such as alcohol use 
disorders18). 
Gambling usually begins in childhood or adolescence, evolving into pathological forms 
into early adulthood, with males tending to start at an earlier age.1,19 This is also the case for 
many manifestations of SUDs.20 Both SUDs and gambling disorder are more frequently 
observed in men, with a telescoping phenomenon observed in females (i.e., women have a later 
initial engagement in the addictive behavior, but foreshortened time period from initial 
 5 
engagement to addiction).21 Although prospective studies are largely lacking, gambling disorder 
appears to follow a trajectory similar to that of substance dependence, with high rates in 
adolescent and young adult groups, lower rates in older adults, and periods of abstinence and 
relapse.17  
Both female and male gamblers report that advertisements are a common trigger of their 
urges to gamble,1,22 a finding redolent of substance addictions in which conditioning is central to 
understanding and treatment: exposure to environmental stimuli previously linked with the 
substance can trigger such urges to re-engage (‘craving’).23,24 Many gamblers experience severe 
financial, social, and/or legal problems,1 as do people with SUDs.8 Both lead to work-related 
problems such as absenteeism, poor performance and unemployment.25  
Many individuals with gambling disorder report the need for psychiatric hospitalization 
owing to depression and related suicidality brought on by their gambling losses.26-28  The often 
overwhelming financial consequences and guilt associated with gambling disorder may also 
contribute to attempted or completed suicide. A study of Gamblers Anonymous participants 
(recruited through a gambling telephone hotline) found that 17% to 24% reported having 
attempted suicide due to gambling.29 SUDs are amongst the psychiatric disorders most predictive 
of suicidality and self-harm, second only to depression, which of course is also common in 
individuals with gambling disorder.30-32  
 
Comorbidity 
Psychiatric comorbidity is common in individuals with gambling disorder. Frequent co-
occurrence has been reported between SUDs (including nicotine dependence) and gambling 
disorder, with the highest odds ratios generally observed between gambling and alcohol use 
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disorders.5, 32-36 Among clinical samples, 52% of Gambler’s Anonymous participants reported 
either alcohol or drug abuse, and 35% to 63% of individuals seeking treatment for gambling 
disorder also screened positive for a lifetime SUD,37 rates notably higher than that found in the 
general population (26.6%).38Studies also demonstrate that individuals with gambling disorder 
have high rates of lifetime mood (60% - 76%), anxiety (16% - 40%), and personality (87%) 
disorders, particularly anti-social personality disorder.39,40  Elevated rates of other behavioral 
addictions (compulsive buying and compulsive sexual behavior) have also been found.39 In a 
systematic review and meta-analysis of the available population surveys exploring comorbid 
disorders in individuals with gambling disorder,41 the strongest associations were with nicotine 
dependence (mean co-morbidity of 60.1% of subjects), followed by SUDs in general (57.5%), 
followed by any mood disorder (37.9%).   
 
Familiality  
Psychiatric disorders are common in the first-degree relatives of those with gambling 
disorder, particularly mood, anxiety, substance use, and antisocial personality disorders. For 
example, earlier studies reported alcohol use disorder in 18-50% of first-degree relatives of 
people with gambling disorder.  More recent studies have incorporated control groups. Black and 
colleagues examined 31 gamblers, 31 control subjects, and first-degree relatives,42 thereby  
quantifying familial aggregation of psychiatric disorders. Lifetime estimates of gambling 
disorder were significantly higher in family members of gamblers (8.3%) compared to control 
subjects (2.1%) (odds ratio of 4.49). Similarly elevated estimates were observed for substance 
use disorders (odds ratio of 4.21). In a separate study conducted in males with gambling disorder 
(n=52) and their first-degree relatives (n=93), higher prevalence of SUDs, problematic gambling, 
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depression, and anxiety disorders were found in first-degree relatives of people with gambling 
disorder versus first-degree relatives of controls.43  
 Twin studies also support etiological overlap between gambling disorder and SUDs. 
Using the Vietnam Era Twin Registry (male adults), statistical models were used to determine 
whether risk factors for DSM-III-R pathological gambling overlapped with those for alcohol 
dependence.44 The authors found that 12-20% of genetic and 3-8% of non-shared environmental 
variation in risk for pathological gambling was accounted for by risk of alcohol dependence. 
Data from the national Australian Twin Registry were used in conjunction with statistical models 
to examine whether genetic risk factors for disordered gambling were shared with alcohol use 
disorders.45 Genetic correlations between these conditions was 0.29-0.44, being particularly 
strong in males, suggesting that up to two-thirds of the association was attributable to shared 
genetic vulnerability. The latter study considered both DSM-IV and DSM-5 definitions for 
gambling disorder /pathological gambling.  
 
Neurocognition 
The behaviors that characterize problematic gambling (e.g., chasing losses, preoccupation 
with gambling, inability to stop) are suggestive of underlying problems with cognitive functions 
dependent on the integrity of fronto-striatal circuitry.48 Such behaviors are impulsive in that they 
are often premature, poorly thought out, risky, and result in deleterious long-term outcomes.49,50 
Deficits across multiple dissociable cognitive functions have been identified in people with 
pathological gambling versus healthy controls, including in aspects of inhibition, working 
memory, planning, cognitive flexibility, and time management/estimation.2,15  
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Studies examining gambling disorder and SUDs have found that both groups are 
characterized by diminished performance on inhibition, time estimation, cognitive flexibility, 
decision-making, spatial working memory, and planning tasks.49 A temporal relationship, 
however, has not been established between cognitive deficits and clinically significant 
symptoms, and these deficits could occur in people ‘at risk’ before symptoms develop, or 
alternatively stem from the disorder itself, perhaps even reflecting a secondary or indeed 
incidental epiphenomenon. Most likely, some cognitive deficits predispose (perhaps running in 
families and representing candidate endophenotypes or intermediate markers of risk50,51), while 
others could be a consequence of recurrent engagement in gambling itself. Certainly some 
aspects of cognitive dysfunction appear to occur not only in people with SUDs but also in their 
clinically unaffected first-degree relatives.52 While studies of cognitive functioning in unaffected 
close relatives of people with gambling disorder are lacking, findings from people ‘at risk’ of 
gambling disorders suggest that deficits in decision-making (dependent on neural circuitry 
including the orbitofrontal and insular cortices) are evident before the illness, while some other 
domains may be relatively spared.53,54  
Gambling addiction represents a useful heuristic model for exploring the ‘cause versus 
effect’ issue in addiction more broadly, since gambling of itself is presumably relatively unlikely 
to subtend toxic effects on the brain, as compared to deleterious effects on brain function 
expected with recurrent use of (at least some types of) illicit substances.  
 
Neurobiology and Pharmacotherapy Treatment 
Multiple neurotransmitter systems have been implicated in the pathophysiology of 
gambling disorder and in SUDs. Dopamine is involved in learning, motivation, and the salience 
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of stimuli, including rewards.  Alterations in dopaminergic pathways have been proposed as 
underlying the seeking of rewards (i.e. gambling; addictive substances) that trigger the release of 
dopamine and produce feelings of pleasure.55  Neuroimaging studies in gambling disorder have 
demonstrated diminished ventral striatum and ventromedial prefrontal cortex/ventrolateral 
prefrontal cortex activity during rewarding events.56,57 Dopamine antagonists acting on D2/D3 
receptors, however, enhance gambling-related motivations and behaviors in patients with 
gambling disorder and have no efficacy in the treatment of gambling disorder.58-60 There is a 
strong body of preclinical evidence arising from over two decades of animal studies suggesting a 
critical role for glutamate transmission and glutamate receptors in drug reward, reinforcement, 
and relapse.61,62 Some data from cerebrospinal fluid studies also suggest a dysfunctional 
glutamate system in gambling disorder.63 Medications that possess a glutamatergic mechanism of 
action (acamprosate, N-acetyl cysteine, gabapentin, lamotrigine, memantine, modafinil, and 
topiramate) have shown benefit for substance use disorders and have some limited but promising 
data for gambling disorder.64,65 Although no medication has received regulatory approval in any 
jurisdiction as a treatment for gambling disorder, there have been 18 double-blind, placebo-
controlled trials of various pharmacological agents (opioid antagonists, glutamatergic agents, 
antidepressants, mood stabilizers). A meta-analysis of randomized trials included 16 outcome 
studies, published between 2000 and 2006 found that pharmacological treatments were more 
effective than placebo treatment at post-treatment (overall effect size = 0.78).66  
Research on the use of opioid antagonists, which have a long history in the treatment of 
substance addictions, has yielded the most promising results for gambling disorder. These 
medications modulate dopaminergic transmission in the mesolimbic pathway and decrease the 
urges to gamble as well as the gambling behavior itself.65 Pooled analyses of those who 
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responded to opioid antagonists demonstrated significant reduction in gambling urges, 
particularly among participants with a positive family history of alcohol dependence.67 Other 
agents, such as those that improve glutamatergic tone in the nucleus accumbens and thereby 
reduce reward-seeking behavior in addictions, or atypical stimulants that reduce impulsivity, 




 Brief treatments (for example, telephone-based motivational interviewing, self-help 
cognitive-behavioral therapy workbook) have shown short and long-term benefit (i.e. at one and 
two year follow-up) for people with gambling disorder.68,69  Positive findings have been reported 
for similar treatments in SUDs.70-72  
In terms of longer psychosocial treatments, a meta-analysis identified 22 randomized 
trials in gambing disorder, published between 1968 and 2004.73 Psychological treatments were 
more effective than no treatment immediately following treatment and/or at follow-up (average 
follow up was 17 months later) (overall effect size = 1.59). Most of the treatment studies 
involved behavioral, cognitive or cognitive-behavioral therapy.  In a Cochrane review of CBT 
studies in gambling disorder, meta-analysis was suggestive of medium-large effect sizes.74 Meta-
analysis of effect sizes for psychosocial treatments for SUDs showed variable effect sizes 
depending on the type of treatment and particular SUD under scrutiny, with largest effects 
reported for CBT plus contingency management; and in the context of cannabis misuse.72  
Although borrowing from treatment studies for SUDs, the evidence-based psychosocial 
treatments for gambling disorder have not aligned identically with traditional substance addiction 
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treatment. Traditional treatment for SUDs has relied on detoxification, group counseling and 
education, and strong links to 12-step programs. The field of gambling treatment has relied more 
on the use of individual psychosocial treatment, and research supports the use of many of the 
same modalities of treatment (e.g., motivational interviewing, CBT, relapse prevention).  
Although perhaps accessed less frequently than in the case of SUDs, 12-step programs 
are widely available for individuals with gambling disorder. Gamblers Anonymous (GA) was 
conceived in 1957 in Los Angeles and currently operates in at least 55 countries worldwide.  
Individuals use a program of twelve steps and twelve traditions, modified from Alcoholics 
Anonymous (AA), to acknowledge powerlessness over compulsive gambling and to remain 
gambling-free. The groups promote a sense of common purpose and understanding as well as 
reinforcement of each consecutive day of abstinence from gambling.  Although some data have 
shown that individuals affiliated with GA have better gambling outcomes than those who do 
not,75 treatment outcome studies that have used referral to GA as a comparison condition to 
cognitive behavioral treatment have shown poor GA attendance and outcomes.75,76 
 
Conclusions 
This selective review has considered evidence for overlap between gambling disorder and 
SUDs from several perspectives. These two types of conditions share remarkable parallels in 
terms of disease onset and course, along with overlapping comorbid expression, and evidence for 
common etiological (genetic and environmental) factors derived from family (including twin) 
studies. Though head-to-head comparisons are generally lacking, impairment in certain cognitive 
functions (e.g. relating to decision-making and reward processing) are likely shared by both 
types of condition, and may even represent predisposing factors occurring prior to the expression 
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of clinically significant symptoms. Similarly, overlapping neuroanatomical and chemical 
systems have been implicated. These streams of research have been complemented by increasing 
recognition of gambling as a ‘behavioral addiction’ in nosological classification, as indicated by 
its inclusion in the Substance Related and Addictive Disorders chapter of DSM-5.8 
While we would argue that viewing gambling from an addiction perspective represents a 
useful heuristic, it is important to note that this perspective is not without its critics, nor is the 
salient literature free of methodological difficulties. From a phenomenological perspective, 
criteria for gambling disorder (and its predecessors) were derived somewhat from SUD criteria; 
that these two types of condition, thusly defined, share overlap in other domains could to some 
extent be a natural consequence of this (‘circular reasoning’). Gambling disorder and SUDs show 
co-morbid overlap, but so too does gambling present concomitantly with other conditions 
(especially depression). That said, a meta-analysis of survey data found that nicotine dependence 
and SUDs in general appeared to be more strongly linked with gambling disorder than other 
disorders.41 Another potential criticism of the ‘addiction approach’ is that it tends to overlook the 
heterogeneity in the expression of these disorders.  Also, a number of unanswered questions 
remain in relation to treatments of gambling disorders and whether approaches should differ 
from those used to treat SUDs. For example, how should concurrent substance addiction be 
addressed in gambling treatment? Should different subtypes of gamblers receive different 
treatments?  Can someone learn to moderate gambling behavior instead of having to be 
abstinent? These questions need empirical examination, and it may be possible to improve our 
treatment outcomes through further investigation of these questions. No study has yet examined 
whether certain individuals with gambling disorder (such as those with versus without comorbid 
SUDs) would benefit differentially from specific medications, and no research has yet 
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determined who would benefit more from pharmacotherapy or cognitive behavioral therapy.  
Finally, our aim here was to provide a concise overview of key research germane to the debate, 
rather than a comprehensive and detailed review. As such, by necessity some topics were 
covered in brief and distilled. We draw the readers’ attention to reviews elsewhere providing 
more detail of specific aspects of gambling disorder.10-15  
It is hoped that reclassification of gambling disorder alongside SUDs, along with 
complementary tiers of research on overlap derived from neurosciences and clinical trials, will 
improve recognition, neurobiological models, and treatment approaches. A number of distinct 
treatment approaches have shown promise in helping those with gambling disorder, with large 
effect sizes at immediate follow-up. As access to multiple types of gambling activities increase 
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